Search research articles
Contact Us
Filters
Showing results (181-190 of 218) with videos related to
Page
of 22
Sort By:
European Journal of Heart Failure
|
November 29, 2021
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
Susana Ravassa, Begoña López, João Pedro Ferreira, et al.
ESC Heart Failure
|
January 29, 2020
Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA-ADHF-DZHK10 trial
Alexander Jobs, Reinhard Vonthein, Inke R König, et al.
European Journal of Heart Failure
|
June 15, 2022
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial
Masatake Kobayashi, Nicolas Girerd, João Pedro Ferreira, et al.
JAMA
|
February 9, 2021
Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
Stephan Mueller, Ephraim B Winzer, André Duvinage, et al.
Nature Medicine
|
January 3, 2025
Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial
Frank Edelmann, Rolf Wachter, André Duvinage, et al.
Nature Medicine
|
February 7, 2025
Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial
Stephan Mueller, Sophia M T Dinges, Felix Gass, et al.
European Journal of Preventive Cardiology
|
March 14, 2025
Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials
Sophia Marie-Theres Dinges, Edzard Schwedhelm, Julia Schoenfeld, et al.
Cardiovascular Diabetology
|
June 18, 2025
Atrial dysfunction: a contrast-free marker for HFpEF in obese diabetics-insights from comprehensive CMR and serum biomarker analyses
Rebecca Elisabeth Beyer, Maximilian Leo Müller, Patrick Doeblin, et al.
ESC Heart Failure
|
September 6, 2022
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial
Luca Monzo, João Pedro Ferreira, John G F Cleland, et al.
ESC Heart Failure
|
July 15, 2022
Peak O<sub>2</sub> -pulse predicts exercise training-induced changes in peak V̇O<sub>2</sub> in heart failure with preserved ejection fraction
Stephan Mueller, Bernhard Haller, Anna Feuerstein, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 218) with videos related to
Sort By:
Page
of 22
European Journal of Heart Failure
|
November 29, 2021
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
Susana Ravassa, Begoña López, João Pedro Ferreira, et al.
ESC Heart Failure
|
January 29, 2020
Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA-ADHF-DZHK10 trial
Alexander Jobs, Reinhard Vonthein, Inke R König, et al.
European Journal of Heart Failure
|
June 15, 2022
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial
Masatake Kobayashi, Nicolas Girerd, João Pedro Ferreira, et al.
JAMA
|
February 9, 2021
Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
Stephan Mueller, Ephraim B Winzer, André Duvinage, et al.
Nature Medicine
|
January 3, 2025
Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial
Frank Edelmann, Rolf Wachter, André Duvinage, et al.
Nature Medicine
|
February 7, 2025
Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial
Stephan Mueller, Sophia M T Dinges, Felix Gass, et al.
European Journal of Preventive Cardiology
|
March 14, 2025
Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials
Sophia Marie-Theres Dinges, Edzard Schwedhelm, Julia Schoenfeld, et al.
Cardiovascular Diabetology
|
June 18, 2025
Atrial dysfunction: a contrast-free marker for HFpEF in obese diabetics-insights from comprehensive CMR and serum biomarker analyses
Rebecca Elisabeth Beyer, Maximilian Leo Müller, Patrick Doeblin, et al.
ESC Heart Failure
|
September 6, 2022
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial
Luca Monzo, João Pedro Ferreira, John G F Cleland, et al.
ESC Heart Failure
|
July 15, 2022
Peak O<sub>2</sub> -pulse predicts exercise training-induced changes in peak V̇O<sub>2</sub> in heart failure with preserved ejection fraction
Stephan Mueller, Bernhard Haller, Anna Feuerstein, et al.
Page
of 22